Tetratherix Limited (ASX:TTX)
Australia · Delayed Price · Currency is AUD 6.63
-0.11 (-1.63%)
Oct 7, 2026, 3:59 PM AEST
Tetratherix Market Cap
Tetratherix has a market cap or net worth of 351.78 million as of October 7, 2026. That makes Tetratherix the world's 19,733rd most valuable company and 373rd in Australia. Its market cap has increased by 70.47% in one year.
Market Cap
351.78M
Enterprise Value
328.38M
Revenue
3.86M
Global Rank
Country Rank
#373 Australia
PE Ratio
n/a
ChartMarket Cap Chart
Since June 30, 2025, Tetratherix's market cap has increased from 152.00M to 351.78M, an increase of 131.43%. That is a compound annual growth rate of 93.49%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 7, 2026 | 351.78M | 113.08% |
| Dec 30, 2025 | 165.09M | 8.61% |
| Jun 30, 2025 | 152.00M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Clarity Pharmaceuticals | 779.74M |
| Clinuvel Pharmaceuticals | 409.98M |
| Starpharma Holdings | 388.63M |
| Racura Oncology | 363.71M |
| BLS Pharmaceuticals | 224.55M |
| Actinogen Medical | 207.78M |
| Orthocell | 196.08M |
| Paradigm Biopharmaceuticals | 146.80M |